1h Free Analyst Time
The animal biotechnology market is forecasted to grow by USD 3654.45 mn during 2023-2028, accelerating at a CAGR of 3.01% during the forecast period. The report on the animal biotechnology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing growth strategies of market players, the growing focus on animal cloning, and the use of transgenic animals to produce recombinant proteins.
The animal biotechnology market is segmented as below:
By Product
- Drugs
- Vaccines
- Diagnostic tests
- Others
By Animal Type
- Livestock/production
- Companion
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the animal biotechnology market covers the following areas:
- Animal biotechnology market sizing
- Animal biotechnology market forecast
- Animal biotechnology market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Animal Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global animal biotechnology market: Anicell BioTech, Bayer AG, Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., EW Group GmBH, Genus Plc, Heska Corp., Hester Biosciences Ltd., IDEXX Laboratories Inc., Ivaoes LLC, Merck and Co. Inc., Neogen Corp., Pfizer Inc., Randox Laboratories Ltd., Santa Cruz Biotechnology Inc., Vimian Group AB, Virbac Group, Z Link Biotech Co. Ltd., and Zeus Biotech Pvt. Ltd..Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is increasing prevalence of animal diseases.'
According to the report, one of the major drivers for this market is the increasing growth strategies of market players.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Anicell BioTech
- Bayer AG
- Biogenesis Bago SA
- Boehringer Ingelheim International GmbH
- Elanco Animal Health Inc.
- EW Group GmBH
- Genus Plc
- Heska Corp.
- Hester Biosciences Ltd.
- IDEXX Laboratories Inc.
- Ivaoes LLC
- Merck and Co. Inc.
- Neogen Corp.
- Pfizer Inc.
- Randox Laboratories Ltd.
- Santa Cruz Biotechnology Inc.
- Vimian Group AB
- Virbac Group
- Z Link Biotech Co. Ltd.
- Zeus Biotech Pvt. Ltd.
